Rucaparib is an orally available potent selective small-molecule inhibitor of poly(ADP-ribose) polymerase (PARP) 1 and 2. Rucaparib induces synthetic lethality in cancer cells defective in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback